Related Experiment Video
Updated: Dec 19, 2025
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
4.3K
[Drug-induced restless legs syndrome]
T M Ostroumova1, O D Ostroumova1,2, Y A Filippova1
1Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Summary
Restless legs syndrome (RLS) is a neurological disorder often triggered by medications. Identifying and managing causative drugs, alongside rational pharmacotherapy, is key to treatment and prevention.
Area of Science:
- Neurology
- Pharmacology
Background:
- Restless legs syndrome (RLS) is a sensorimotor disorder characterized by an urge to move the legs, typically worsening at night.
- Drug-induced RLS is a recognized condition linked to various medications, including antipsychotics, antidepressants, and antiepileptics.
Purpose of the Study:
- To review the causes, risk factors, mechanisms, and management strategies for drug-induced restless legs syndrome.
Main Methods:
- Literature review of studies reporting drug-induced RLS.
- Analysis of risk factors, implicated drug classes, and proposed mechanisms.
- Summary of treatment and prevention approaches.
Main Results:
- Common risk factors for drug-induced RLS include advanced age, gastrointestinal issues, high drug dosage, and polypharmacy.
- The underlying mechanism often involves medication effects on neurotransmitter systems, particularly dopamine.
- Treatment primarily involves drug withdrawal or dose reduction.
Conclusions:
- Drug-induced RLS is a significant concern, necessitating careful medication review.
- Adherence to rational pharmacotherapy principles is crucial for preventing drug-induced RLS.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
385
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
385
01:15REM Sleep Behavior Disorder
1.0K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
1.0K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
404
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
404
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.0K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.0K
01:21Skeletal Muscle Relaxants: Adverse Effects
709
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
709
01:28Classification of Skeletal Muscle Relaxants
2.9K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.9K